333
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab

, , &
Pages 1001-1004 | Received 21 Jun 2012, Accepted 24 Jan 2013, Published online: 18 Feb 2014

References

  • Horler AR, Thompson M. The pleural and pulmonary complications of rheumatoid arthritis. Ann Inter Med.. 1959;51: 1179–1203.
  • Walker WC, Wright V. Rheumatoid pleuritis. Ann Rheum Dis. 1967;26: 467–474
  • Takemura T. Pathological features of the lung in rheumatoid arthritis (in Japanese). Nikkyou.. 2007;66(6): 470–484.
  • Kelly CA. Rheumatoid arthritis; classical rheumatoid lung disease. Clin Rheumatol.. 1993;7: 1–16.
  • Juric AG, Davidsen D, Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients: a radiological and clinical study. Scand J Rheumatol. 1982;11: 217
  • Zrour SH, Touzi M, Bejia I. Correlation between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Joint Bone Spine.. 2005;72: 41
  • Watanabe A. Pulmonary infection caused by anti-tumor necrotizing factor-α (in Japanese). Kokyuu.. 2005;24(12): 985–992.
  • Nakayama H, Kamide Y, Hamano Y, Hosokawa T, Nishide M, Lin Y, et al. A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment. Mod Rheumatol. 2011;21: 655–659
  • Bongartz T, Suttou AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA.. 2006;295: 2275–2285
  • Faurschou P. Decreased glucose in RA-cell-positive pleural effusion. Eur J Resp Dis.. 1984;65: 272–277.
  • Petterson T, Klockars M, Weber T. Pulmonal fluid adenosine diaminase activity in rheumatoid arthritis and systemic lupus erythematosus. Chest. 1984;86: 237
  • Ocana I, Ribera E, Martinez-Vazoquez JM, Ruiz I, Bejarano E, Pigrau C, et al. Adenosine diaminase activity in rheumatoid pleural effusion. Ann Rheum Dis.. 1988;47: 394–397
  • Huggins John T, Sahn Steven A. Drug-induced pleural disease. Clin Chest Med. 2004;25: 141–153
  • Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, et al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis.. 2008;67: 189–194
  • Tsukada T, Fujikawa K, Inoue Y, Nagasako K, Nakamura H, Ida A, et al. Two cases of pleuritis with rheumatoid arthritis which were treated with anti-TNFα agents (in Japanese). Kyusyu Riumachi.. 2010;30(2): 94–96.
  • Kasai S, Tokuda H, Otsuka Y, Ookouti Y, Handa H, Emoto N, et al. Two cases of respiratory complicating treatment with infliximab (in Japanese). Nihon Kokyu Kaishi.. 2007;45(4): 366–371.
  • Takasaka N, Toyota E, Shimada M, Ariga H, Teramoto S, Akagawa S. Two cases of tuberculosis after treatment of rheumatoid arthritis with infliximab (in Japanese). Nihon Kokyu Kaishi.. 2010;48(1): 60–65.
  • Nakashita T, Yamada I, Inoue A, Okada T, Toda M, Motojima S. A case of rheumatoid arthritis developed tuberculosis during the treatment with infliximab (in Japanese). Nikkyo.. 2006;65(8): 749–755.
  • Tanoue LT. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 1999;19: 667–685
  • Avnon LS, Abu-Shakr M, Flusser D, Heimer D, Sion-Vardy N. Pleural effusion associated with rheumatoid arthritis: what cell dominance to anticipate. Rheumatol Int.. 2007;27(10): 919–925
  • Turesson C, Matterson E. Management of extra-articular disease manifestation in rheumatoid arthritis. Curr Opin Rheumatol. 2004;16: 204
  • Chapman PT, O’Donnell JL, Moller PW. Rheumatoid pleural effusion: response to intrapleural corticosteroid. J Rheumatol. 1992;19: 478
  • Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006;35: 368–378
  • Ozaki Y, Tanaka A, Shimamoto K, Amuro H, Kawakami K, Son Y, et al. A case of rheumatoid pericarditis associated with a high IL-6 titer in the pericardial fluid and tocilizumab treatment. Mod Rheumatol. 2011;21: 302–304

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.